Table 5.
Variables | Per-protocol set | ||||
---|---|---|---|---|---|
BSFC | BSYQ | Placebo | F | P value | |
n = 88 | n = 98 | n = 86 | |||
CRH (logarithm) | |||||
Before treatment | 0.45 ± 0.57 | 0.40 ± 0.55 | 0.64 ± 0.59 | 2.954 | 0.0548 |
Min–max | −1.27~1.85 | −1.89~1.30 | −1.00~2.02 | ||
After treatment | 0.47 ± 0.60 | 0.44 ± 0.70 | 0.12 ± 0.87 | 3.101 | 0.0492 |
Min–max | −0.79~1.81 | −1.55~1.64 | −2.58~1.87 | ||
ACTH | |||||
Before treatment | 0.68 ± 0.20 | 0.77 ± 0.70 | 1.43 ± 1.95 | 9.556 | 0.001 |
Min–max | 0.12~1.28 | 0.08~6.89 | 0.27~6.96 | ||
After treatment | 1.59 ± 1.88 | 0.78 ± 0.41 | 0.64 ± 0.23 | 5.274 | 0.0069 |
Min–max | 0.40~6.53 | 0.42~1.99 | 0.13~1.21 | ||
CORT | |||||
Before treatment | 13.09 ± 7.64 | 15.72 ± 7.76 | 19.51 ± 10.20 | 8.726 | 0.0002 |
Min–max | 0.20~45.95 | 1.23~52.87 | 6.65~49.68 | ||
After treatment | 12.24 ± 8.11 | 13.09 ± 6.90 | 8.93 ± 5.99 | 3.989 | 0.0222 |
Min–max | 1.64~29.45 | 3.68~36.43 | 0.23~22.22 |